Logo image of FGNXP

FUNDAMENTAL GROUP INC - FGF 8 PERP (FGNXP) Stock Fundamental Analysis

NASDAQ:FGNXP - US30329Y2054

18 USD
-0.82 (-4.36%)
Last: 9/9/2025, 8:00:00 PM
Fundamental Rating

2

FGNXP gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 146 industry peers in the Insurance industry. FGNXP may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, FGNXP is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year FGNXP has reported negative net income.
FGNXP had a negative operating cash flow in the past year.
FGNXP had negative earnings in 4 of the past 5 years.
FGNXP had a negative operating cash flow in each of the past 5 years.
FGNXP Yearly Net Income VS EBIT VS OCF VS FCFFGNXP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

1.2 Ratios

The Return On Assets of FGNXP (-8.25%) is worse than 91.78% of its industry peers.
FGNXP's Return On Equity of -12.89% is on the low side compared to the rest of the industry. FGNXP is outperformed by 89.04% of its industry peers.
Industry RankSector Rank
ROA -8.25%
ROE -12.89%
ROIC N/A
ROA(3y)-0.21%
ROA(5y)-18.87%
ROE(3y)-0.16%
ROE(5y)-20.05%
ROIC(3y)N/A
ROIC(5y)N/A
FGNXP Yearly ROA, ROE, ROICFGNXP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

FGNXP does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FGNXP Yearly Profit, Operating, Gross MarginsFGNXP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 2K 4K 6K

More info and screens

3

2. Health

2.1 Basic Checks

FGNXP does not have a ROIC to compare to the WACC, probably because it is not profitable.
FGNXP has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, FGNXP has less shares outstanding
Compared to 1 year ago, FGNXP has a worse debt to assets ratio.
FGNXP Yearly Shares OutstandingFGNXP Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
FGNXP Yearly Total Debt VS Total AssetsFGNXP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

FGNXP has an Altman-Z score of 0.36. This is a bad value and indicates that FGNXP is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of FGNXP (0.36) is better than 69.86% of its industry peers.
A Debt/Equity ratio of 0.05 indicates that FGNXP is not too dependend on debt financing.
FGNXP has a better Debt to Equity ratio (0.05) than 83.56% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 0.36
ROIC/WACCN/A
WACC8.37%
FGNXP Yearly LT Debt VS Equity VS FCFFGNXP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

FGNXP has a Current Ratio of 0.47. This is a bad value and indicates that FGNXP is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.47, FGNXP is in the better half of the industry, outperforming 73.97% of the companies in the same industry.
A Quick Ratio of 0.47 indicates that FGNXP may have some problems paying its short term obligations.
FGNXP has a Quick ratio of 0.47. This is in the better half of the industry: FGNXP outperforms 73.97% of its industry peers.
Industry RankSector Rank
Current Ratio 0.47
Quick Ratio 0.47
FGNXP Yearly Current Assets VS Current LiabilitesFGNXP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 31.23% over the past year.
Looking at the last year, FGNXP shows a very strong growth in Revenue. The Revenue has grown by 51.88%.
FGNXP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 41.74% yearly.
EPS 1Y (TTM)31.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.67%
Revenue 1Y (TTM)51.88%
Revenue growth 3YN/A
Revenue growth 5Y41.74%
Sales Q2Q%29.61%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FGNXP Yearly Revenue VS EstimatesFGNXP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M
FGNXP Yearly EPS VS EstimatesFGNXP Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 5 10

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

FGNXP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FGNXP Price Earnings VS Forward Price EarningsFGNXP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FGNXP Per share dataFGNXP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.83%, FGNXP is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.63, FGNXP pays a better dividend. On top of this FGNXP pays more dividend than 94.52% of the companies listed in the same industry.
FGNXP's Dividend Yield is rather good when compared to the S&P500 average which is at 2.46.
Industry RankSector Rank
Dividend Yield 7.83%

5.2 History

FGNXP has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A
FGNXP Yearly Dividends per shareFGNXP Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

FGNXP has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-17.02%
EPS Next 2YN/A
EPS Next 3YN/A
FGNXP Yearly Income VS Free CF VS DividendFGNXP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

More info and screens

FUNDAMENTAL GROUP INC - FGF 8 PERP

NASDAQ:FGNXP (9/9/2025, 8:00:00 PM)

18

-0.82 (-4.36%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)08-07 2025-08-07
Earnings (Next)11-12 2025-11-12
Inst Owners34.15%
Inst Owner ChangeN/A
Ins Owners12.31%
Ins Owner ChangeN/A
Market Cap23.94M
AnalystsN/A
Price TargetN/A
Short Float %0.01%
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield 7.83%
Yearly Dividend1.67
Dividend Growth(5Y)N/A
DP-17.02%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-Date09-02 2025-09-02 (0.5)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.71
P/FCF N/A
P/OCF N/A
P/B 0.37
P/tB 0.37
EV/EBITDA N/A
EPS(TTM)-5.58
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-5.02
FCFYN/A
OCF(TTM)-4.99
OCFYN/A
SpS25.25
BVpS48.24
TBVpS48.24
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.25%
ROE -12.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-0.21%
ROA(5y)-18.87%
ROE(3y)-0.16%
ROE(5y)-20.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5.74%
Cap/Sales 0.12%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.47
Quick Ratio 0.47
Altman-Z 0.36
F-Score3
WACC8.37%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)4.97%
Cap/Sales(5y)4.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)51.88%
Revenue growth 3YN/A
Revenue growth 5Y41.74%
Sales Q2Q%29.61%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-4313.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-13.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-12.69%
OCF growth 3YN/A
OCF growth 5YN/A